Citations

Clear

4093 citation(s) found for "Yu, Jonathan".

T1 and FLAIR signal intensities are related to tau pathology in dominantly inherited Alzheimer disease
Brier, Matthew R. , Gordon, Brian A. , Flores, Shaney , Keefe, Sarah , Hornbeck, Russ C. , Ances, Beau M. , Xiong, Chengjie , Wang, Guoqiao , Raji, Cyrus A. , Libre‐Guerra, Jorge J., Perrin, Richard J. , Daniels, Alisha , Day, Gregory S. , Fulham, Michael , Jack, Clifford R. , Fougère, Christian la , Oh, Hwamee , Vöglein, Jonathan , Yakushev, Igor , Morris, John C. , (DIAN), For the Dominantly Inherited Alzheimer Network, Rahmani, Farzaneh , Cash, David M , Jack, Clifford R , Gordon, Brian A , Day, Gregory S , Vöglein, Jonathan , Xiong, Chengjie , Ances, Beau M , Morris, John C , McKay, Nicole S. , Joseph‐Mathurin, Nelly , Xiong, Chengjie , McDade, Eric , Karch, Celeste M. , Brickman, Adam M. , Reischl, Gerald , Schofield, Peter R. , Cash, David M. , Ikeuchi, Takeshi , Klunk, William E. , Bateman, Randall J. , Benzinger, Tammie L.S. , (DIAN), For the Dominantly Inherited Alzheimer Network

Mayo Clinic

Human Brain Mapping | October 23, 2023 | Volume: 44 | Issue: 18 | Pages: 6375-6387

10.1002/hbm.26514 | PMID 37867465 Get It

AbstractCarriers of mutations responsible for dominantly inherited Alzheimer disease provide a unique opportunity to study potential imaging biomarkers. Biomarkers based on routinely acquired clinical MR images, could supplement the extant invasive or logistically challenging) biomarker studies. We used 1104 longitudinal MR, 324 amyloid beta, and 87 tau positron emission tomography imaging sessions from 525 participants enrolled in the Dominantly Inherited Alzheimer Network Observational Study to extract novel imaging metrics representing the mean (μ) and standard deviation (σ) of standardized image intensities of T1‐weighted and Fluid attenuated inversion recovery (FLAIR) MR scans. There was an exponential decrease in FLAIR‐μ in mutation carriers and an increase in FLAIR and T1 signal heterogeneity (T1‐σ and FLAIR‐σ) as participants approached the symptom onset in both supramarginal, the right postcentral and right superior temporal gyri as well as both caudate nuclei, putamina, thalami, and amygdalae. After controlling for the effect of regional atrophy, FLAIR‐μ decreased and T1‐σ and FLAIR‐σ increased with increasing amyloid beta and tau deposition in numerous cortical regions. In symptomatic mutation carriers and independent of the effect of regional atrophy, tau pathology demonstrated a stronger relationship with image intensity metrics, compared with amyloid pathology. We propose novel MR imaging intensity‐based metrics using standard clinical T1 and FLAIR images which strongly associates with the progression of pathology in dominantly inherited Alzheimer disease. We suggest that tau pathology may be a key driver of the observed changes in this cohort of patients.
Intraoperative Surgeon Assessment of Bone
Bernatz, James T. , Skjaerlund, Jonathan, Mikula, Anthony L. , Johnson, Sarah E. , Bydon, Mohamad , Fogelson, Jeremy L. , Elder, Benjamin D. , Sebastian, Arjun S. , Freedman, Brett A. , Goh, Brian C, Skjaerlund, Jonathan D, Fogelson, Jeremy, Elder, Benjamin, Huddleston, Paul, Karim, Mohammed, Sebastian, Arjun, Goh, Brian Chun Kim , Huddleston, P.M. , Karim, Mohammed, Nassr, Ahmad

Mayo Clinic

Spine | October 19, 2023 | Volume: 49 | Issue: 16 | Pages: 1125-1129

10.1097/brs.0000000000004854 | PMID 37855301 Get It

Study design. Retrospective observational study of consecutive patients. Objective. The purpose of the study is to determine if a surgeon’s qualitative assessment of bone intraoperatively correlates with radiologic parameters of bone strength. Summary of Background Data. Preoperative radiologic assessment of bone can include modalities such as computed tomography (CT) Hounsfield units (HUs), dual-energy x-ray absorptiometry (DXA) bone mineral density with trabecular bone score (TBS) and magnetic resonance imaging vertebral bone quality (VBQ). Quantitative analysis of bone with screw insertional torque and pull-out strength measurement has been performed in cadaveric models and has been correlated to these radiologic parameters. However, these quantitative measurements are not routinely available for use in surgery. Surgeons anecdotally judge bone strength, but the fidelity of the intraoperative judgment has not been investigated. Methods. All adult patients undergoing instrumented posterior thoracolumbar spine fusion by one of seven surgeons at a single center over a 3-month period were included. Surgeons evaluated the strength of bone based on intraoperative feedback and graded each patient’s bone on a 5-point Likert scale. Two independent reviewers measured preoperative CT HUs and magnetic resonance imaging VBQ. Bone mineral density, lowest T-score, and TBS were extracted from DXA within 2 years of surgery. Results. Eighty-nine patients were enrolled and 16, 28, 31, 13, and 1 patients had Likert grade 1 (strongest bone), 2, 3, 4, and 5 (weakest bone), respectively. The surgeon assessment of bone correlated with VBQ (τ=0.15, P=0.07), CT HU (τ=−0.31, P<0.01), lowest DXA T-score (τ=−0.47, P<0.01), and TBS (τ=−0.23, P=0.06). Conclusion. Spine surgeons’ qualitative intraoperative assessment of bone correlates with preoperative radiologic parameters, particularly in posterior thoracolumbar surgeries. This information is valuable to surgeons as this supports the idea that decisions based on feel in surgery have a statistical foundation.
S192 Evaluating the Burden and Predictors of Colorectal Neoplastic Lesions in Young Patients Undergoing Diagnostic Colonoscopy
Pisipati, Sailaja , Gurudu, Rachana, Arguichona, Joseph, Lim, Elisabeth S. , Aguilar, Maria T., Samadder, N. Jewel , Leighton, Jonathan A. , Ramirez, Francisco C. , Gurudu, Suryakanth, Kunze, Katie L.

Mayo Clinic

American Journal of Gastroenterology | October 18, 2023 | Volume: 118 | Issue: 10S | Pages: S144-S145

10.14309/01.ajg.0000950408.41745.34 Get It

S875 Atovaquone and Proguanil vs Hepatitis A Vaccine, Hydroxychloroquine, and Mesalamine in Patients With IBD: A Propensity Score Matched Cohort Comparison of Strategically Selected Comparators
Nadeem, Ahmed, Pérez, Jaime A. , Dulai, Parambir S. , Sandborn, William J. , David, Aidan J., Cooper, Gregory S. , Leighton, Jonathan A. , David, Joseph , Hanauer, Stephen B. , Regueiro, Miguel , Mansoor, Emad

Mayo Clinic

American Journal of Gastroenterology | October 18, 2023 | Volume: 118 | Issue: 10S | Pages: S651-S651

10.14309/01.ajg.0000953140.01023.e0 Get It

S874 Impact of Atovaquone and Proguanil on Steroid Use, Hospitalization, and Advanced Therapeutic Use in Patients With IBD: A Propensity Matched Cohort Study
Nadeem, Ahmed, Pérez, Jaime A. , Dulai, Parambir S. , Sandborn, William J. , David, Aidan J., Cooper, Gregory S. , Leighton, Jonathan A. , David, Joseph , Hanauer, Stephen B. , Regueiro, Miguel , Mansoor, Emad

Mayo Clinic

American Journal of Gastroenterology | October 18, 2023 | Volume: 118 | Issue: 10S | Pages: S650-S650

10.14309/01.ajg.0000953136.72575.4f Get It

S834 Clinical Efficacy of Video Capsule Endoscopy and Balloon-Assisted in Suspected Small Bowel Bleeding: A Single Center Cohort Study
Elmasry, Sandra , Song, Kevin , Tuck, Jacyln, Pasha, Shabana F., Leighton, Jonathan A. , Lizaola‐Mayo, Blanca , Ruff, Kevin

Mayo Clinic

American Journal of Gastroenterology | October 18, 2023 | Volume: 118 | Issue: 10S | Pages: S617-S617

10.14309/01.ajg.0000952976.91378.39 Get It

S829 Urgent Balloon Assisted Enteroscopy in Acute Overt Suspected Small Bowel Bleeding Is Associated With Decreased Rehospitalization Rate and Increased Bleeding Free Survival
Song, Kevin , Elmasry, Sandra , Tuck, Jaclyn , Pasha, Shabana F., Leighton, Jonathan A. , Lizaola‐Mayo, Blanca , Ruff, Kevin

Mayo Clinic

American Journal of Gastroenterology | October 18, 2023 | Volume: 118 | Issue: 10S | Pages: S614-S614

10.14309/01.ajg.0000952956.46042.61 Get It

S753 Clinical, Endoscopic and Histologic Features of Common Variable Immunodeficiency
Fluxá, Daniela , AlAhmad, Maryam , Loeb, Lauren , Squire, Jacqueline D. , Ha, Christina , Pardi, Darrell S. , Bi, Yan , Kinnucan, Jami , Picco, Michael F., Leighton, Jonathan A. , Squire, Jacqueline , Farraye, Francis A. , Hashash, Jana G.

Mayo Clinic

American Journal of Gastroenterology | October 18, 2023 | Volume: 118 | Issue: 10S | Pages: S550-S551

10.14309/01.ajg.0000952652.69791.c8 Get It

Advancing Tau-PET quantification in Alzheimer's disease with machine learning: introducing THETA, a novel tau summary measure
Gebre, Robel K , Raghavan, Sheela Kumari, Wiste, Heather J. , Sparrman, Kohl L. Johnson, Costoya‐Sánchez, Alejandro , Schwarz, Christopher G. , Spychalla, Anthony J., Lowe, Val J. , Graff‐Radford, Jonathan , Petersen, Ronald C. , Schöll, Michael , Vemuri, Prashanthi , Rial, Alexis Moscoso , Johnson Sparrman, Kohl L, Schwarz, Christopher G , Knopman, David S. , Petersen, Ronald C , Schöll, Michael , Jack, Clifford R , Vemuri, Prashanthi , Heeman, Fiona , Knopman, David S. , Jack, Clifford R.

Mayo Clinic

No container title available | October 18, 2023 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-3290598/v1 | PMID 37886506 Get It

Abstract Alzheimer's disease (AD) exhibits spatially heterogeneous 3R/4R tau pathology distributions across participants, making it a challenge to quantify extent of tau deposition. Utilizing Tau-PET from three independent cohorts, we trained and validated a machine learning model to identify visually positive Tau-PET scans from regional SUVR values and developed a novel summary measure, THETA, that accounts for heterogeneity in tau deposition. The model for identification of tau positivity achieved a balanced test accuracy of 95% and accuracy of ≥87% on the validation datasets. THETA captured heterogeneity of tau deposition, had better association with clinical measures, and corresponded better with visual assessments in comparison with the temporal meta-region-of-interest Tau-PET quantification methods. Our novel approach aids in identification of positive Tau-PET scans and provides a quantitative summary measure, THETA, that effectively captures the heterogeneous tau deposition seen in AD. The application of THETA for quantifying Tau-PET in AD exhibits great potential.
Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study
Nagaraj, Gayathri , Vinayak, Shaveta , Sun, Tianyi , Kuderer, Nicole M. , Bakouny, Ziad , Balmaceda, Nicole , Bilen, Mehmet Asım , Bindal, Poorva , Blau, Sibel , Bodin, Brianne E, Borno, Hala T. , Castellano, Cecilia A. , Choi, Horyun, Deeken, John F. , Desai, Aakash , Edwin, Natasha, Feldman, Lawrence , Flora, Daniel , Galsky, Matthew D. , Gonzalez, Cyndi J, Grivas, Petros , Gupta, Shilpa , Haynam, Marcy , Heilman, Hannah, Jani, Chinmay , Jhawar, Sachin R, Kaklamani, Virginia , Klein, Elizabeth J. , Koshkin, Vadim S. , Kulkarni, Amit , Kwon, Daniel H. , Lammers, Philip E. , Lathrop, Kate, Lewis, Mark A. , Li, Xuanyi , Lopes, Gilbert de Lima, Makower, Della , Mansoor, Abdul-Hai, Mashru, Sandeep H., McKay, Rana R. , Messing, Ian , Mico, Vasil, Nadkarni, Rajani, Namburi, Swathi, Nguyen, Ryan H, Nonato, Taylor K., O’Connor, Tracey L. , Park, Kyu, Patel, Jaymin , Patel, Kanishka G. , Peppercorn, Jeffrey , Polimera, Hyma , Puc, Matthew , Rao, Yuan James , Reid, Sonya , Riess, Jonathan W. , Rivera, Donna R. , Rose, Suzanne J. , Russ, Atlantis Dawn, Schapira, Lidia , Shah, Pankil , Shanahan, M Kelly, Smits, Melissa, Streckfuss, Mitrianna, Thompson, Michael A, Tolaney, Sara M. , Weissmann, Lisa B., Wilson, Grace, Wulff‐Burchfield, Elizabeth , French, Benjamin , Lustberg, Maryam B. , Accordino, Melissa , Sun, Tianyi , Hwang, Clara , Puc, Matthew M , Mishra, Sanjay , Accordino, Melissa K , Desai, Aakash P , Bakouny, Ziad , Bilen, Mehmet A , Lustberg, Maryam , Khaki, Ali Raza , Aboulafia, David M. , Acoba, Jared David , Awosika, Joy A. , Bao, Ting , Bashir, Babar , Berg, Stephanie , Friese, Christopher R. , Hershman, Dawn L. , Hwang, Clara , Jhawar, Sachin R, Joshi, Monika , Knox, Natalie, Labaki, Chris , Lyman, Gary H , Markham, Merry Jennifer , Nguyen, Ryan H, Panagiotou, Orestis A. , Razavi, Pedram , Robson, Mark E. , Shapiro, Lauren C. , Stover, Daniel G. , Tachiki, Lisa , Wotman, Michael T. , Mishra, Sanjay , Warner, Jeremy L. , Shah, Dimpy P.

Mayo Clinic

eLife | October 17, 2023 | Volume: 12 | Issue: No issue available | Pages: No page available

10.7554/elife.82618 | PMID 37846664 Get It

Background: Limited information is available for patients with breast cancer (BC) and coronavirus disease 2019 (COVID-19), especially among underrepresented racial/ethnic populations. Methods: This is a COVID-19 and Cancer Consortium (CCC19) registry-based retrospective cohort study of females with active or history of BC and laboratory-confirmed severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection diagnosed between March 2020 and June 2021 in the US. Primary outcome was COVID-19 severity measured on a five-level ordinal scale, including none of the following complications, hospitalization, intensive care unit admission, mechanical ventilation, and all-cause mortality. Multivariable ordinal logistic regression model identified characteristics associated with COVID-19 severity. Results: 1383 female patient records with BC and COVID-19 were included in the analysis, the median age was 61 years, and median follow-up was 90 days. Multivariable analysis revealed higher odds of COVID-19 severity for older age (aOR per decade, 1.48 [95% CI, 1.32–1.67]); Black patients (aOR 1.74; 95 CI 1.24–2.45), Asian Americans and Pacific Islander patients (aOR 3.40; 95 CI 1.70–6.79) and Other (aOR 2.97; 95 CI 1.71–5.17) racial/ethnic groups; worse ECOG performance status (ECOG PS ≥2: aOR, 7.78 [95% CI, 4.83–12.5]); pre-existing cardiovascular (aOR, 2.26 [95% CI, 1.63–3.15])/pulmonary comorbidities (aOR, 1.65 [95% CI, 1.20–2.29]); diabetes mellitus (aOR, 2.25 [95% CI, 1.66–3.04]); and active and progressing cancer (aOR, 12.5 [95% CI, 6.89–22.6]). Hispanic ethnicity, timing, and type of anti-cancer therapy modalities were not significantly associated with worse COVID-19 outcomes. The total all-cause mortality and hospitalization rate for the entire cohort was 9% and 37%, respectively however, it varied according to the BC disease status. Conclusions: Using one of the largest registries on cancer and COVID-19, we identified patient and BC-related factors associated with worse COVID-19 outcomes. After adjusting for baseline characteristics, underrepresented racial/ethnic patients experienced worse outcomes compared to non-Hispanic White patients. Funding: This study was partly supported by National Cancer Institute grant number P30 CA068485 to Tianyi Sun, Sanjay Mishra, Benjamin French, Jeremy L Warner; P30-CA046592 to Christopher R Friese; P30 CA023100 for Rana R McKay; P30-CA054174 for Pankil K Shah and Dimpy P Shah; KL2 TR002646 for Pankil Shah and the American Cancer Society and Hope Foundation for Cancer Research (MRSG-16-152-01-CCE) and P30-CA054174 for Dimpy P Shah. REDCap is developed and supported by Vanderbilt Institute for Clinical and Translational Research grant support (UL1 TR000445 from NCATS/NIH). The funding sources had no role in the writing of the manuscript or the decision to submit it for publication. Clinical trial number: CCC19 registry is registered on ClinicalTrials.gov, NCT04354701 .